Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Net Income: 2018-2025

Historic Net Income for Bicycle Therapeutics (BCYC) over the last 8 years, with Sep 2025 value amounting to -$59.1 million.

  • Bicycle Therapeutics' Net Income fell 16.33% to -$59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.4 million, marking a year-over-year decrease of 53.84%. This contributed to the annual value of -$174.8 million for FY2024, which is 3.49% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Net Income of -$59.1 million as of Q3 2025, which was up 25.14% from -$79.0 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Net Income peaked at -$14.7 million during Q3 2021, and registered a low of -$79.0 million during Q2 2025.
  • Moreover, its 3-year median value for Net Income was -$49.9 million (2023), whereas its average is -$50.4 million.
  • As far as peak fluctuations go, Bicycle Therapeutics' Net Income skyrocketed by 32.13% in 2024, and later plummeted by 129.10% in 2025.
  • Bicycle Therapeutics' Net Income (Quarterly) stood at -$19.1 million in 2021, then crashed by 94.02% to -$37.0 million in 2022, then tumbled by 34.01% to -$49.6 million in 2023, then declined by 16.31% to -$57.6 million in 2024, then dropped by 16.33% to -$59.1 million in 2025.
  • Its last three reported values are -$59.1 million in Q3 2025, -$79.0 million for Q2 2025, and -$60.7 million during Q1 2025.